Loratadine
0,01 g № 10
Pharmacotherapeutic group
Active ingredient
Pharmaceutical form
Tablets
ATC code
R06AX13
RX/OTC
OTC
Registration certificate
UA/4033/01/01
General properties
Pharmacotherapeutic group
Antihistamines for systemic use.
Therapeutic indications
Symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.
Contraindications
Loratadine is contraindicated in patients with hypersensitivity to the active substances or to any other component of the drug.
Pharmaceutical characteristics
Main physicochemical properties
Tablets of white or almost white with a break line and bevel.
Shelf life
3 years.
Storage
Store in a dark premises out of reach of children at temperature not exceeding 25 °C.
Manufacturer
PJSC "Lekhim-Kharkiv".
Location
36, Severyna Pototskoho St., 61115 Kharkiv, Ukraine.
